UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

The European respiratory journal, 2021-04, Vol.57 (4), p.2003690

2021

Volltextzugriff (PDF)

Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro

Angiogenesis (London), 2018-11, Vol.21 (4), p.861-871

2018

Volltextzugriff (PDF)

Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC

Respiratory research, 2018-01, Vol.19 (1), p.7-7, Article 7

2018

Volltextzugriff (PDF)

Increased Expiratory Computed Tomography Density Reveals Possible Abnormalities in Radiologically Preserved Lung Parenchyma in Idiopathic Pulmonary Fibrosis

Investigative radiology, 2018-01, Vol.53 (1), p.45-51

2018

Volltextzugriff (PDF)

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19

Journal of central nervous system disease, 2022-05, Vol.14, p.11795735221102727-11795735221102727

2022

Volltextzugriff (PDF)

Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization

American journal of respiratory cell and molecular biology, 2016-07, Vol.55 (1), p.105-116

2016

Volltextzugriff (PDF)

Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected]

Respiratory research, 2020-01, Vol.21 (1), p.25-25, Article 25

2020

Volltextzugriff (PDF)

Autochthonous Case of Pulmonary Histoplasmosis, Switzerland

Emerging infectious diseases, 2021-03, Vol.27 (3), p.966-969

2021

Volltextzugriff (PDF)

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study

ERJ open research, 2019-04, Vol.5 (2), p.209

2019

Volltextzugriff (PDF)

Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case-control study

Respiratory research, 2021-04, Vol.22 (1), p.120-120, Article 120

2021

Volltextzugriff (PDF)

Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study

Respiratory research, 2022-06, Vol.23 (1), p.149-149, Article 149

2022

Volltextzugriff (PDF)

Imaging in the aftermath of COVID-19: what to expect

European radiology, 2021-06, Vol.31 (6), p.4390-4392

2021

Volltextzugriff (PDF)

Evaluation of a Novel Ear Pulse Oximeter: Towards Automated Oxygen Titration in Eyeglass Frames

Sensors (Basel, Switzerland), 2020-06, Vol.20 (11), p.3301

2020

Volltextzugriff (PDF)

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges

ERJ open research, 2022-04, Vol.8 (2), p.115

2022

Volltextzugriff (PDF)

Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphies

Respiratory research, 2017-11, Vol.18 (1), p.190-190, Article 190

2017

Volltextzugriff (PDF)

Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19

Frontiers in medicine, 2021-05, Vol.8, p.644678-644678

2021

Volltextzugriff (PDF)

Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls

Respiratory research, 2020-01, Vol.21 (1), p.29-29, Article 29

2020

Volltextzugriff (PDF)

Influence of ventilation inhomogeneity on diffusing capacity of carbon monoxide in smokers without COPD

ERJ open research, 2021-01, Vol.7 (1), p.706

2021

Volltextzugriff (PDF)

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation

ERJ open research, 2022-10, Vol.8 (4), p.469

2022

Volltextzugriff (PDF)

Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts

BMJ open respiratory research, 2021-01, Vol.8 (1), p.e000827

2021

Volltextzugriff (PDF)

Systemic corticosteroids in fibrotic lung disease: a systematic review and meta-analysis

BMJ open respiratory research, 2023-12, Vol.10 (1), p.e002008

2023

Volltextzugriff (PDF)

Frailty assessment for COVID-19 follow-up: a prospective cohort study

BMJ open respiratory research, 2022-04, Vol.9 (1), p.e001227

2022

Volltextzugriff (PDF)

Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis

ERJ open research, 2023-05, Vol.9 (3), p.720

2023

Volltextzugriff (PDF)

The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury

American journal of respiratory cell and molecular biology, 2012-03, Vol.46 (3), p.355-364

2012

Volltextzugriff (PDF)

The Octopus Sign-A New HRCT Sign in Pulmonary Langerhans Cell Histiocytosis

Diagnostics (Basel), 2022-04, Vol.12 (4), p.937

2022

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Aktive Filter

KollektionBMJ_英国医学会期刊

KollektionSpringerLink

Zeitschrift / SerieSwiss Medical Weekly

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(47)
Respiratory System
(30)
Humans
(22)
Pulmonary Fibrosis
(20)
Idiopathic Pulmonary Fibrosis
(13)
Male
(11)
Lung Diseases
(10)
Female
(9)
Covid-19
(8)
Diagnosis
(7)
Fibroblasts
(7)
Fibrosis
(7)
Interstitial Lung Disease
(7)
Lung - Pathology
(7)
Animals
(6)
General & Internal Medicine
(6)
Idiopathic Pulmonary Fibrosis - Diagnosis
(6)
Pathology
(6)
Patients
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro

Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC

Increased Expiratory Computed Tomography Density Reveals Possible Abnormalities in Radiologically Preserved Lung Parenchyma in Idiopathic Pulmonary Fibrosis

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19

Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization

Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected]

Autochthonous Case of Pulmonary Histoplasmosis, Switzerland

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study

Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case-control study

Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study

Imaging in the aftermath of COVID-19: what to expect

Evaluation of a Novel Ear Pulse Oximeter: Towards Automated Oxygen Titration in Eyeglass Frames

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges

Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphies

Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19

Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls

Influence of ventilation inhomogeneity on diffusing capacity of carbon monoxide in smokers without COPD

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation

Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts

Systemic corticosteroids in fibrotic lung disease: a systematic review and meta-analysis

Frailty assessment for COVID-19 follow-up: a prospective cohort study

Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis

The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury

The Octopus Sign-A New HRCT Sign in Pulmonary Langerhans Cell Histiocytosis

Aktive Filter

Suchergebnisse filtern